UnknownPhase 4

Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis

Albania, Bulgaria, Italy300 participantsStarted 2017-12-01

Plain-language summary

With this study the investigators want to test which is the best medical treatment for symptomatic adenomyosis affecting women undergoing IVF and with previous implantation failure, between Aromatase inhibitor plus GnRH analog versus GnRH alone, in term pregnancy rate and uterine volume reduction.

Who can participate

Age range30 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * women with healty conditions * Adenomyosis * increased uterine dimensions * recurrent implantation failure Exclusion Criteria: * presence of systemic diseases

What they're measuring

pregnancy after embryo transfer

Timeframe: 12 months

Trial details

NCT IDNCT03421639

SponsorCentre for Endocrinology and Reproductive Medicine, Italy

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2024-09-30

View on ClinicalTrials.gov More Uterine Adenomyosis trials